RayzeBio, Inc. (RYZB)

NASDAQ: RYZB · IEX Real-Time Price · USD
-0.23 (-1.02%)
Nov 28, 2023, 4:00 PM EST - Market closed

Total Valuation

RayzeBio has a market cap or net worth of $1.34 billion. The enterprise value is $809.62 million.

Market Cap 1.34B
Enterprise Value 809.62M

Important Dates

The last earnings date was Monday, November 13, 2023, after market close.

Earnings Date Nov 13, 2023
Ex-Dividend Date n/a

Share Statistics

RayzeBio has 59.92 million shares outstanding. The number of shares has increased by 472.44% in one year.

Shares Outstanding 59.92M
Shares Change (YoY) +472.44%
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.33
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 31.85, with a Debt / Equity ratio of 0.02.

Current Ratio 31.85
Quick Ratio n/a
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$753,909
Employee Count 88
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
52-Week Price Change n/a
50-Day Moving Average 20.73
200-Day Moving Average n/a
Relative Strength Index (RSI) 57.28
Average Volume (30 Days) 301,617

Short Selling Information

The latest short interest is 1.70 million, so 2.84% of the outstanding shares have been sold short.

Short Interest 1.70M
Short Previous Month 1.73M
Short % of Shares Out 2.84%
Short % of Float n/a
Short Ratio (days to cover) 3.11

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income n/a
Pretax Income n/a
Net Income -66.34M
EBIT n/a
Earnings Per Share (EPS) -$1.21
Full Income Statement

Balance Sheet

The company has $540.51 million in cash and $9.72 million in debt, giving a net cash position of $530.78 million or $8.86 per share.

Cash & Cash Equivalents 540.51M
Total Debt 9.72M
Net Cash 530.78M
Net Cash Per Share $8.86
Equity / Book Value 575.32M
Book Value Per Share 9.60
Working Capital 527.87M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RayzeBio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -4.95%
FCF Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -472.44%
Shareholder Yield -472.44%

Analyst Forecast

The average price target for RayzeBio is $31.33, which is 40.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target $31.33
Price Target Difference 40.05%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score n/a